期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Assessment and Visualization of Ki67 Heterogeneity in Breast Cancers through Digital Image Analysis
1
作者 Chien-Hui Wu Min-Hsiang Chang +1 位作者 Hsin-Hsiu Tsai Yi-Ting Peng 《Advances in Breast Cancer Research》 CAS 2024年第2期11-26,共16页
The Ki67 index (KI) is a standard clinical marker for tumor proliferation;however, its application is hindered by intratumoral heterogeneity. In this study, we used digital image analysis to comprehensively analyze Ki... The Ki67 index (KI) is a standard clinical marker for tumor proliferation;however, its application is hindered by intratumoral heterogeneity. In this study, we used digital image analysis to comprehensively analyze Ki67 heterogeneity and distribution patterns in breast carcinoma. Using Smart Pathology software, we digitized and analyzed 42 excised breast carcinoma Ki67 slides. Boxplots, histograms, and heat maps were generated to illustrate the KI distribution. We found that 30% of cases (13/42) exhibited discrepancies between global and hotspot KI when using a 14% KI threshold for classification. Patients with higher global or hotspot KI values displayed greater heterogenicity. Ki67 distribution patterns were categorized as randomly distributed (52%, 22/42), peripheral (43%, 18/42), and centered (5%, 2/42). Our sampling simulator indicated analyzing more than 10 high-power fields was typically required to accurately estimate global KI, with sampling size being correlated with heterogeneity. In conclusion, using digital image analysis in whole-slide images allows for comprehensive Ki67 profile assessment, shedding light on heterogeneity and distribution patterns. This spatial information can facilitate KI surveys of breast cancer and other malignancies. 展开更多
关键词 ki67 heterogeneity Breast Cancer Digital Image Analysis
下载PDF
乳腺癌分子病理学指标分布的异质性 被引量:4
2
作者 陈洁 吕青 +4 位作者 王竹 杜正贵 谭秋文 王强 曾荷淋 《中国普外基础与临床杂志》 CAS 2016年第6期761-766,共6页
目的总结乳腺癌分子病理学指标分布异质性的相关研究。方法采用文献复习的方法,对有关乳腺癌分子病理学指标分布情况的文献加以综述。结果乳腺癌同其他上皮性肿瘤一样存在异质性,且决定乳腺癌分子分型的雌激素受体(estrogen receptor,ER... 目的总结乳腺癌分子病理学指标分布异质性的相关研究。方法采用文献复习的方法,对有关乳腺癌分子病理学指标分布情况的文献加以综述。结果乳腺癌同其他上皮性肿瘤一样存在异质性,且决定乳腺癌分子分型的雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)、人类表皮生长因子受体2(human epidermal growth factor receptor-2,HER-2)及Ki-67这四种特征性分子病理学指标在肿瘤组织中的分布均存在异质性。乳腺癌分子病理学指标分布的异质性会导致常规病理诊断对这四种指标检测的不准确、甚至错误,进而影响患者治疗方案的选择,并在一定程度上影响患者的预后。结论虽然已有不少新技术用于乳腺癌异质性的研究,但由于各种方法均存在一定的缺陷,且有关的报道较少,仍需要进一步深入研究以揭示乳腺癌异质性的原因及规律,并寻找减少其影响的可靠方法。 展开更多
关键词 异质性 乳腺癌 雌激素受体 孕激素受体 人类表皮生长因子受体2 ki-67
原文传递
Proliferation Characteristics of CD133+ Cell Population in Colorectal Cancer
3
作者 于冬冬 张永红 +6 位作者 邹游 覃吉超 李小兰 肖徽 陶德定 胡俊波 龚建平 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2010年第6期751-756,共6页
In this study,CD133+ subpopulations were isolated from 41 primary colorectal cancer tissues,the proliferation and cell cycle distribution of the cells were examined without in vitro expansion,and then compared to thos... In this study,CD133+ subpopulations were isolated from 41 primary colorectal cancer tissues,the proliferation and cell cycle distribution of the cells were examined without in vitro expansion,and then compared to those of cell lines.The detection of CD133 in colorectal cancer tissues,isolation of CD133+ and CD133-epithelial subpopulations,Ki-67/DNA multiparameter assay and cell volume analysis were flow cytometrically conducted.The results showed that Ki-67 expression was correlated with CD133 level in primary cancer tissues,while cell cycle G 2 /M phase distribution or clinicopathological characteristics was not.In addition,the CD133+ cells showed larger cell volume and higher Ki-67 expression as compared with CD133-cells.But there was no statistically significant difference in G 2 /M phase distribution between the two subpopulations.Our results demonstrated that the CD133+ subpopulation in colorectal cancer tissue contained more actively cycling and proliferating cells,which was not correlated to clinicopathological factors but might contribute to tumor progression and poor clinical outcome. 展开更多
关键词 CD133 cancer stem cell ki-67 cell cycle tumor heterogeneity colorectal cancer
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部